Spots Global Cancer Trial Database for Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma
Official Title: Phase II Study of Nab-Paclitaxel in Combination With Gemcitabine for Treatment of Recurrent/Refractory Sarcoma in Teenagers and Young Adults
Study ID: NCT02945800
Study Description
Brief Summary: The purpose of this study is to see if nab-paclitaxel combined with gemcitabine prevents the formation or growth of tumors in participants with relapsed or refractory osteosarcoma, Ewing sarcoma, rhabdomyosarcoma and other soft tissue sarcoma and to measure the length of time during and after treatment that their disease does not get worse. Researchers also want to find out if nab-paclitaxel combined with gemcitabine is safe and tolerable.
Detailed Description:
Eligibility
Minimum Age: 3 Years
Eligible Ages: CHILD, ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham, Alabama, United States
Children's Hospital Los Angeles, Los Angeles, California, United States
Connecticut Children's Medical Center, Hartford, Connecticut, United States
A.I. duPont Hospital for Children, Delaware - Nemours, Wilmington, Delaware, United States
Shand's Hospital for Children at the University of Florida, Gainesville, Florida, United States
Nemours Children's Clinic, Jacksonville, Florida, United States
Holtz Children's Hospital at the University of Miami, Miami, Florida, United States
H. Lee Moffitt Cancer Center and Research Institute, Coordinating Center, Tampa, Florida, United States
University of Kentucky, Lexington, Kentucky, United States
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
Carolinas Medical Center, Levine Cancer Institute, Charlotte, North Carolina, United States
Nationwide Children's Hospital, Columbus, Ohio, United States
Vanderbilt - Ingram Cancer Center, Nashville, Tennessee, United States
Contact Details
Name: Javier E. Oesterheld, M.D.
Affiliation: Carolinas Medical Center, Levine Cancer Institute
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
